NDATF (NDatalyze) Current Accrued Expense: $0.03 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NDatalyze Current Accrued Expense?

NDatalyze NDATF Current Accrued Expense is $0.03 Mil as of May. 2026. The stock has 1 warning sign investors should review.

NDatalyze's Current Accrued Expense for the quarter that ended in May. 2026 was $0.03 Mil.

NDatalyze's quarterly Current Accrued Expense declined from Nov. 2025 ($0.01 Mil) to Feb. 2026 ($0.01 Mil) but then increased from Feb. 2026 ($0.01 Mil) to May. 2026 ($0.03 Mil).

NDatalyze's annual Current Accrued Expense declined from Feb. 2024 ($0.03 Mil) to Feb. 2025 ($0.02 Mil) and declined from Feb. 2025 ($0.02 Mil) to Feb. 2026 ($0.01 Mil).

NDatalyze Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for NDatalyze's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDatalyze Current Accrued Expense Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Current Accrued Expense
Get a 7-Day Free Trial 0.06 0.22 0.03 0.02 0.01

NDatalyze Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 0.03

NDatalyze Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.03 Mil mean?
NDatalyze (NDATF) has a Current Accrued Expense of $0.03 Mil as of May. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on NDatalyze and its competitors.
Is NDatalyze's Current Accrued Expense too high?
NDatalyze's current Current Accrued Expense is $0.03 Mil.
How does NDatalyze's Current Accrued Expense compare to VEEV and BTSG?
NDatalyze's Current Accrued Expense of $0.03 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Healthcare Providers & Services company?
A good Current Accrued Expense depends on the Healthcare Providers & Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on NDatalyze and its competitors. NDatalyze's current Current Accrued Expense is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
NDatalyze (NDATF) has a current Current Accrued Expense of $0.03 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Current Accrued Expense is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For NDatalyze (NDATF), the current Current Accrued Expense is $0.03 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NDatalyze Business Description

Other Exchanges NDAT:Canada
Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.